Literature DB >> 21227476

Extraneural manifestations of prion infection in GPI-anchorless transgenic mice.

Andrew M Lee1, Johan F Paulsson, Justin Cruite, Abegail A Andaya, Matthew J Trifilo, Michael B A Oldstone.   

Abstract

Earlier studies indicated that transgenic (tg) mice engineered to express prion protein (PrP) lacking the glycophosphatidylinositol (GPI⁻/⁻) membrane anchor formed abnormal proteinase-resistant prion (PrPsc) amyloid deposits in their brains and hearts when infected with the RML strain of murine scrapie. In contrast, RML scrapie infection of normal mice with a GPI-anchored PrP did not deposit amyloid with PrPsc in the brain or the heart. Here we report that scrapie-infected GPI⁻/⁻ PrP tg mice also deposit PrP and transmissible infectious material in the gut, kidneys, and islets of Langerhans. Similar to previously reported amyloid deposits in the brain and heart, amyloid deposits were found in the gut; however, no amyloid deposited in the islets. By high-resolution electron microscopy, we show PrP is located primarily in α cells and also β cells. Islets contain abundant insulin and there is no abnormality in glucose metabolism in infected GPI⁻/⁻ PrP tg mice.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21227476      PMCID: PMC3039103          DOI: 10.1016/j.virol.2010.12.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  Discovery and characterization of a mammalian amyloid disaggregation activity.

Authors:  Amber N Murray; James P Solomon; Ya-Juan Wang; William E Balch; Jeffery W Kelly
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

2.  Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes.

Authors:  A Clark; G J Cooper; C E Lewis; J F Morris; A C Willis; K B Reid; R C Turner
Journal:  Lancet       Date:  1987-08-01       Impact factor: 79.321

3.  Mapping of the major histocompatibility complex and viral antigens on the plasma membrane of a measles virus-infected cell.

Authors:  M B Oldstone; R S Fujinami; A Tishon; D Finney; H C Powell; P W Lampert
Journal:  Virology       Date:  1983-06       Impact factor: 3.616

4.  Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH.

Authors:  Y Matsunaga; D Peretz; A Williamson; D Burton; I Mehlhorn; D Groth; F E Cohen; S B Prusiner; M A Baldwin
Journal:  Proteins       Date:  2001-08-01

5.  Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients.

Authors:  R Narita; H Toshimori; M Nakazato; T Kuribayashi; T Toshimori; K Kawabata; K Takahashi; S Masukura
Journal:  Diabetes Res Clin Pract       Date:  1992-01       Impact factor: 5.602

6.  A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas.

Authors:  P Westermark; C Wernstedt; E Wilander; K Sletten
Journal:  Biochem Biophys Res Commun       Date:  1986-11-14       Impact factor: 3.575

7.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

8.  Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus.

Authors:  A Lorenzo; B Razzaboni; G C Weir; B A Yankner
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

9.  Scrapie-induced diabetes mellitus in hamsters.

Authors:  J Srinivasappa; D M Asher; K L Pomeroy; L J Murphy; A V Wolff; J W Yoon; D C Gajdusek; A L Notkins
Journal:  Microb Pathog       Date:  1989-09       Impact factor: 3.738

10.  Virus persists in beta cells of islets of Langerhans and is associated with chemical manifestations of diabetes.

Authors:  M B Oldstone; P Southern; M Rodriquez; P Lampert
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

View more
  6 in total

1.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

2.  Lack of prion infectivity in fixed heart tissue from patients with Creutzfeldt-Jakob disease or amyloid heart disease.

Authors:  Suzette A Priola; Anne E Ward; Sherman A McCall; Matthew Trifilo; Young Pyo Choi; Laura Solforosi; R Anthony Williamson; Justin T Cruite; Michael B A Oldstone
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

3.  Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain.

Authors:  Sukhvir Paul Mahal; Joseph Jablonski; Irena Suponitsky-Kroyter; Anja Maria Oelschlegel; Maria Eugenia Herva; Michael Oldstone; Charles Weissmann
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

4.  Post-translational modifications in PrP expand the conformational diversity of prions in vivo.

Authors:  Patricia Aguilar-Calvo; Xiangzhu Xiao; Cyrus Bett; Hasier Eraña; Katrin Soldau; Joaquin Castilla; K Peter R Nilsson; Witold K Surewicz; Christina J Sigurdson
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

5.  Distribution of peripheral PrP(Sc) in sheep with naturally acquired scrapie.

Authors:  María Carmen Garza; Marta Monzón; Belén Marín; Juan José Badiola; Eva Monleón
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

6.  A novel prion disease associated with diarrhea and autonomic neuropathy.

Authors:  Simon Mead; Sonia Gandhi; Janice L Holton; John Collinge; Jon Beck; Diana Caine; Dillip Gallujipali; Christopher Carswell; Harpreet Hyare; Susan Joiner; Hilary Ayling; Tammaryn Lashley; Jacqueline M Linehan; Huda Al-Doujaily; Bernadette Sharps; Tamas Revesz; Malin K Sandberg; Mary M Reilly; Martin Koltzenburg; Alastair Forbes; Peter Rudge; Sebastian Brandner; Jason D Warren; Jonathan D F Wadsworth; Nicholas W Wood
Journal:  N Engl J Med       Date:  2013-11-14       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.